Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036341 (
schizophrenia
)
60,220
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present study reports on the association between
Phenylthiocarbamide
tasting for paranoid and nonparanoid schizophrenic patients. The incidence of PTC tasting is highly variable, and tasters and nontasters are frequently associated with some pathological states. 25 paranoid and 25 nonparanoid schizophrenic patients were examined for their PTC taste sensitivity. Frequency of paranoid tasters resembles the distribution of the normal population, whereas the nonparanoid patients are significantly different in their taste thresholds, with a higher incidence of nontasters. The members of this latter group have twice the incidence of psychiatric illness in their family histories as those of the former group. The significance of these findings is discussed as related to vulnerability for
schizophrenia
.
...
PMID:Phenylthiocarbamide (PTC) tasting in paranoid and nonparanoid schizophrenic patients. 159 98
Phenylthiocarbamide
(
PTC
) taste sensitivity is an inherited trait determined primarily by allelic variation of the taste-receptor gene TAS2R38 on chromosome 7q. Results of prior studies examining the ability to taste
PTC
in patients with
schizophrenia
have been mixed because of the difficulties in measuring
PTC
taste sensitivity behaviorally. In the current study, we examined the TAS2R38 genotypes of
schizophrenia
patients to determine whether the increased prevalence of nontasters in this patient population was indicative of a specific genetic association. Our a-priori hypothesis was that
schizophrenia
patients would show an increased prevalence of the nontaster phenotype compared with controls. The genotypes of two nonsynonymous coding single-nucleotide polymorphisms in TAS2R38 were assayed for 176
schizophrenia
patients and 229 healthy control individuals, and the two-allele haplotypes were estimated. There was an over-representation of the major
PTC
nontaster haplotype among patients of European descent, relative to control individuals of similar ancestry. Patients and controls of African ancestry did not differ. The
PTC
nontaster haplotype is a genetic marker that may be used to identify subsets of
schizophrenia
patients who potentially harbor vulnerability genes in this region of chromosome 7q.
...
PMID:Association of schizophrenia with the phenylthiocarbamide taste receptor haplotype on chromosome 7q. 2295 40